Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Endometrial Neoplasms × apatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 53 Carcinoma, Hepatocellular 38 Carcinoma, Non-Small-Cell Lung 21 Small Cell Lung Carcinoma 18 Ovarian Neoplasms 17 Colorectal Neoplasms 15 Breast Neoplasms 13 Sarcoma 12 Triple Negative Breast Neoplasms 11 Nasopharyngeal Carcinoma 11 Neoplasms 10 Esophageal Squamous Cell Carcinoma 10 Esophageal Neoplasms 9 Cholangiocarcinoma 9 Neoplasm Metastasis 7 Squamous Cell Carcinoma of Head and Neck 6 Recurrence 6 Osteosarcoma 6 Lung Neoplasms 6 Head and Neck Neoplasms 6 Biliary Tract Neoplasms 6 Advanced Gastric Cancer 6 Uterine Cervical Neoplasms 5 Solid Tumor 4 Pancreatic Neoplasms 4 Melanoma 4 Liver Neoplasms 4 Thyroid Neoplasms 3 NSCLC 3 Glioma 3

Interventions

Paclitaxel 79 Carboplatin 63 pembrolizumab 57 Bevacizumab 24 Cisplatin 23 Letrozole 19 Radiotherapy 18 Doxorubicin 18 olaparib 16 lenvatinib 16 Megestrol Acetate 16 Taxes 15 dostarlimab 14 Specimen Handling 14 Nivolumab 14 Metformin 13 Docetaxel 13 Fulvestrant 11 durvalumab 10 Magnetic Resonance Spectroscopy 10 temsirolimus 9 abemaciclib 9 Trastuzumab 9 Radiation 9 Medroxyprogesterone Acetate 9 Gemcitabine 9 Brachytherapy 9 Biopsy 9 Observation 8 Indocyanine Green 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06771154 2025-01-13

A-CAPE

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡